DJIA 18,143.55 46.65 0.26%
NASDAQ 4,989.53 22.39 0.45%
S&P 500 2,103.30 4.77 0.23%
market minute promo

VIVUS, Inc. (NASDAQ: VVUS)

2.94 -0.04 (-1.34%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VVUS $2.94 -1.34%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.97
Previous Close $2.98
Daily Range $2.90 - $3.00
52-Week Range $2.41 - $6.40
Market Cap $305.4M
P/E Ratio -3.73
Dividend (Yield) $0.00 (0.0%)
Volume 326,764
Average Daily Volume 2,131,189
Current FY EPS -$1.26

Sector

Healthcare

Industry

Drug Makers

VIVUS, Inc. (VVUS) Description

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products. Website:

News & Commentary Rss Feed

Why Orexigen Therapeutics, Inc. Stock Exploded Higher

Orexigen Therapeutics looks like it has the first game-changing obesity drug on its hands. Here's what you need to know.

Orexigen Soars: Good News Is Heart Data, Bad News Is Data May Be Compromised

Cardiovascular Safety Surprise: Wait, Then Buy Orexigen

Orexigen Weight-Loss Pill Shows Surprise Heart-Safety Benefit

Vivus - Flat Qsymia Scripts Point To Needed Shift

Vivus Sinking With Dwindling Qsymia Market Share

Orexigen's Q4 Results Disappoint, But Contrave Is Gaining Market Share

Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst B

Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst Blog

Orexigen Therapeutics, Inc. Gives the Skinny on Its Drug Launch

Fourth-quarter earnings were nothing to get excited about, but the Contrave launch trajectory looks good so far.

VIVUS Q4 Loss Wider than Expected, Qsymia Disappoints - Analyst Blog

See More VVUS News...

VVUS's Top Competitors

VVUS $2.94 (-1.34%)
Current stock: VVUS
JNJ $102.85 (1.18%)
Current stock: JNJ
NVS $99.46 (0.42%)
Current stock: NVS
RHHBY $33.09 (-0.20%)
Current stock: RHHBY